196 related articles for article (PubMed ID: 17331954)
21. Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
Woods CG; Kosyk O; Bradford BU; Ross PK; Burns AM; Cunningham ML; Qu P; Ibrahim JG; Rusyn I
Toxicol Appl Pharmacol; 2007 Dec; 225(3):267-77. PubMed ID: 17950772
[TBL] [Abstract][Full Text] [Related]
22. Evidence that reduction of hepatocyte growth factor (HGF) is not required for peroxisome proliferator-induced hepatocyte proliferation.
Kiss A; Ortiz-Aguayo R; Sharp R; Merlino G; Thorgeirsson SS; Gonzalez FJ; Peters JM
Carcinogenesis; 2001 Jun; 22(6):975-9. PubMed ID: 11375907
[TBL] [Abstract][Full Text] [Related]
23. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
24. Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators.
Tamasi V; Miller KK; Ripp SL; Vila E; Geoghagen TE; Prough RA
Mol Pharmacol; 2008 Mar; 73(3):968-76. PubMed ID: 18079279
[TBL] [Abstract][Full Text] [Related]
25. Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase.
Woods CG; Burns AM; Maki A; Bradford BU; Cunningham ML; Connor HD; Kadiiska MB; Mason RP; Peters JM; Rusyn I
Free Radic Biol Med; 2007 Feb; 42(3):335-42. PubMed ID: 17210446
[TBL] [Abstract][Full Text] [Related]
26. Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver.
Guo D; Sarkar J; Suino-Powell K; Xu Y; Matsumoto K; Jia Y; Yu S; Khare S; Haldar K; Rao MS; Foreman JE; Monga SP; Peters JM; Xu HE; Reddy JK
J Biol Chem; 2007 Dec; 282(50):36766-76. PubMed ID: 17962186
[TBL] [Abstract][Full Text] [Related]
27. Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver.
Sarkar J; Qi C; Guo D; Ahmed MR; Jia Y; Usuda N; Viswakarma N; Rao MS; Reddy JK
Gene Expr; 2007; 13(4-5):255-69. PubMed ID: 17605299
[TBL] [Abstract][Full Text] [Related]
28. Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice.
Huang J; Viswakarma N; Yu S; Jia Y; Bai L; Vluggens A; Cherkaoui-Malki M; Khan M; Singh I; Yang G; Rao MS; Borensztajn J; Reddy JK
Am J Pathol; 2011 Aug; 179(2):703-13. PubMed ID: 21801867
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte-specific PPARA expression exclusively promotes agonist-induced cell proliferation without influence from nonparenchymal cells.
Brocker CN; Yue J; Kim D; Qu A; Bonzo JA; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G283-G299. PubMed ID: 28082284
[TBL] [Abstract][Full Text] [Related]
30. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
Melnick RL
Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor alpha-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells.
Yamashita M
Eur J Pharmacol; 2007 Feb; 556(1-3):172-80. PubMed ID: 17113579
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent PPARĪ± activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene.
Tian Y; Yang Y; Zhang X; Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Lu Y; Moriya K; Koike K; Gonzalez FJ; Aoyama T
Glycoconj J; 2016 Dec; 33(6):927-936. PubMed ID: 27318478
[TBL] [Abstract][Full Text] [Related]
33. trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals.
Shipley JM; Hurst CH; Tanaka SS; DeRoos FL; Butenhoff JL; Seacat AM; Waxman DJ
Toxicol Sci; 2004 Jul; 80(1):151-60. PubMed ID: 15071170
[TBL] [Abstract][Full Text] [Related]
34. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
Hasmall SC; West DA; Olsen K; Roberts RA
Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
[TBL] [Abstract][Full Text] [Related]
35. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.
Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC
Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644
[TBL] [Abstract][Full Text] [Related]
36. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
[TBL] [Abstract][Full Text] [Related]
37. Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators.
Rusyn I; Rose ML; Bojes HK; Thurman RG
Antioxid Redox Signal; 2000; 2(3):607-21. PubMed ID: 11229371
[TBL] [Abstract][Full Text] [Related]
38. Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity.
Sapiro JM; Mashek MT; Greenberg AS; Mashek DG
J Lipid Res; 2009 Aug; 50(8):1621-9. PubMed ID: 19304987
[TBL] [Abstract][Full Text] [Related]
39. Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).
Howroyd P; Swanson C; Dunn C; Cattley RC; Corton JC
Toxicol Pathol; 2004; 32(5):591-9. PubMed ID: 15603543
[TBL] [Abstract][Full Text] [Related]
40. The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha.
Yang Q; Nagano T; Shah Y; Cheung C; Ito S; Gonzalez FJ
Toxicol Sci; 2008 Jan; 101(1):132-9. PubMed ID: 17690133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
